Stay updated on Safety and Tolerability of Dupilumab in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Safety and Tolerability of Dupilumab in Atopic Dermatitis Clinical Trial page.
Latest updates to the Safety and Tolerability of Dupilumab in Atopic Dermatitis Clinical Trial page
- Check3 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant revision.SummaryDifference0.2%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check39 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.SummaryDifference3%
- Check53 days agoChange DetectedThe website has added new features for user interaction while removing detailed options for participant groups, interventions, and various data fields related to studies.SummaryDifference4%
- Check60 days agoChange DetectedSeveral key health-related links have been removed, including those from MedlinePlus and PubMed, which may affect access to important genetic and medical information.SummaryDifference0.5%
- Check68 days agoChange DetectedThe website has been updated to version 2.12.2, adding several new links related to genetics, eczema, and clinical studies, while removing the previous version 2.12.1.SummaryDifference5%
Stay in the know with updates to Safety and Tolerability of Dupilumab in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Tolerability of Dupilumab in Atopic Dermatitis Clinical Trial page.